29 filings
Page 2 of 2
8-K
zin16x
30 Jun 22
Aura Biosciences Receives FDA Fast Track Designation for Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle
7:31am
8-K
16ucpakdwf
22 Jun 22
Regulation FD Disclosure
5:02pm
8-K
5t1z8fe9hqc duwkqgdm
15 Jun 22
Submission of Matters to a Vote of Security Holders
5:02pm
8-K
4fbtzkqu qqoemz5zss
26 May 22
Regulation FD Disclosure
6:04pm
8-K
qmp2honz4t0y8wt5r32x
18 May 22
Entry into a Material Definitive Agreement
4:06pm
8-K
0e109cro
12 May 22
Aura Biosciences Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
4:29pm
8-K
j72hw
23 Mar 22
Aura Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights
4:21pm
8-K
tn9d0nz0awqkivp4
24 Nov 21
Aura Biosciences Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
4:15pm
8-K
ysoeo1nn3scq31t
2 Nov 21
Amendments to Articles of Incorporation or Bylaws
4:06pm